Who Attends
Patients as Partners EU is where pharma and patient advocacy leadership share best practices on the implementation of patient partnering to drive greater efficiencies in medicines development. Each session demonstrates the what, where, when and how to co-create solutions with patients and measure the impact of those initiatives. Together we are advancing patient participation for greater diversity, access and better clinical outcomes.
Patients as Partners EU Attendees Get Access to the Following Benefits:
• 50+ Multi-stakeholder speakers
• 17+ Hours of discussion
• 17+ Sessions covering strategies to involve patients in medicines development
• 10+ Networking activities
• 14+ Pharmaceutical company and patient-led presentations on a specific example of collaborating with patients
8 Essential Topic Areas Covered
- Turning patient insights into action
- Mapping and demonstrating value for patient engagement
- Patient burden-reducing solutions and technologies
- HTA/Regulatory requirements and patient engagement in drug development
- The future of patient informed research
- Patient preferences and decentralized clinical trials
- Advancing health equity and diversifying clinical trials
- The patient experience data landscape
Join 200+ Leaders from
Industry Segments
• Mid-to-large pharma
• Biotech (all sizes)
• Patient Advocacy Organizations
• Government
• CROs
• Clinical technology, mobile, digital, AI and service companies
• Academia
Titles/ Functions
• Heads of Patient Engagement/ Involvement/ Recruitment
• VPs/ Directors of Clinical Operations & Outsourcing
• Heads of Patient Advocacy
• Clinical Development Innovation Directors
• VPs of Clinical Affairs
• Clinical External Alliance Directors
2025 Sponsors
